@article{AdnanSrsicVenticichetal.2020, author = {Adnan, Hassan Sami and Srsic, Amanda and Venticich, Pete Milos and Townend, David M.R.}, title = {Using AI for mental health analysis and prediction in school surveys}, series = {European journal of public health}, volume = {30}, journal = {European journal of public health}, publisher = {Oxford Univ. Press}, address = {Oxford [u.a.]}, issn = {1101-1262}, doi = {10.1093/eurpub/ckaa165.336}, pages = {V125 -- V125}, year = {2020}, abstract = {Background: Childhood and adolescence are critical stages of life for mental health and well-being. Schools are a key setting for mental health promotion and illness prevention. One in five children and adolescents have a mental disorder, about half of mental disorders beginning before the age of 14. Beneficial and explainable artificial intelligence can replace current paper- based and online approaches to school mental health surveys. This can enhance data acquisition, interoperability, data driven analysis, trust and compliance. This paper presents a model for using chatbots for non-obtrusive data collection and supervised machine learning models for data analysis; and discusses ethical considerations pertaining to the use of these models. Methods: For data acquisition, the proposed model uses chatbots which interact with students. The conversation log acts as the source of raw data for the machine learning. Pre-processing of the data is automated by filtering for keywords and phrases. Existing survey results, obtained through current paper-based data collection methods, are evaluated by domain experts (health professionals). These can be used to create a test dataset to validate the machine learning models. Supervised learning can then be deployed to classify specific behaviour and mental health patterns. Results: We present a model that can be used to improve upon current paper-based data collection and manual data analysis methods. An open-source GitHub repository contains necessary tools and components of this model. Privacy is respected through rigorous observance of confidentiality and data protection requirements. Critical reflection on these ethics and law aspects is included in the project. Conclusions: This model strengthens mental health surveillance in schools. The same tools and components could be applied to other public health data. Future extensions of this model could also incorporate unsupervised learning to find clusters and patterns of unknown effects.}, language = {en} } @article{KonigorskiWernickeSlosareketal.2021, author = {Konigorski, Stefan and Wernicke, Sarah and Slosarek, Tamara and Zenner, Alexander Maximilian and Strelow, Nils and Ruether, Darius Ferenc Ruether and Henschel, Florian and Manaswini, Manisha and Pottb{\"a}cker, Fabian and Edelman, Jonathan Antonio and Owoyele, Babajide and Danieletto, Matteo and Golden, Eddye and Zweig, Micol and Nadkarni, Girish N. and B{\"o}ttinger, Erwin}, title = {StudyU: A Platform for Designing and Conducting Innovative Digital N-of-1 Trials}, series = {Journal of Medical Internet Research}, volume = {24}, journal = {Journal of Medical Internet Research}, edition = {7}, publisher = {JMIR Publications}, address = {Richmond, Virginia, USA}, issn = {1438-8871}, doi = {10.2196/35884}, pages = {12}, year = {2021}, abstract = {N-of-1 trials are the gold standard study design to evaluate individual treatment effects and derive personalized treatment strategies. Digital tools have the potential to initiate a new era of N-of-1 trials in terms of scale and scope, but fully functional platforms are not yet available. Here, we present the open source StudyU platform, which includes the StudyU Designer and StudyU app. With the StudyU Designer, scientists are given a collaborative web application to digitally specify, publish, and conduct N-of-1 trials. The StudyU app is a smartphone app with innovative user-centric elements for participants to partake in trials published through the StudyU Designer to assess the effects of different interventions on their health. Thereby, the StudyU platform allows clinicians and researchers worldwide to easily design and conduct digital N-of-1 trials in a safe manner. We envision that StudyU can change the landscape of personalized treatments both for patients and healthy individuals, democratize and personalize evidence generation for self-optimization and medicine, and can be integrated in clinical practice.}, language = {en} }